Keyphrases
Matrix metalloproteinase-9 (MMP-9)
100%
Endothelial Nitric Oxide Synthase (eNOS)
100%
Agmatine
100%
Cerebral Endothelial Cell
100%
Protein Level
33%
Nitric Oxide Production
33%
Ischemic Injury
33%
Matrix metalloproteinase-2 (MMP-2)
33%
MRNA Level
22%
Western Blot
22%
Matrix Metalloproteinases
22%
Ischemia-reperfusion Injury
22%
Oxygen-glucose Deprivation
22%
Nitric Oxide Synthase Inhibitors
22%
L-NAME
22%
Cell Death
11%
Quantitative PCR
11%
Treatment Group
11%
Expression Level
11%
Immunohistochemical Analysis
11%
Nitric Oxide
11%
Neuroprotective Effect
11%
Insults
11%
Basement Membrane
11%
Tissue Injury
11%
Study Support
11%
Brain Cells
11%
BEnd.3 Cells
11%
Nitric Oxide Release
11%
Griess Reagent
11%
Brain Vessels
11%
Objective Matrix
11%
Cultured Endothelial Cells
11%
Pharmacology, Toxicology and Pharmaceutical Science
Gelatinase B
100%
Endothelial Nitric Oxide Synthase
100%
Agmatine
100%
Nitric Oxide
55%
Injury
33%
Gelatinase A
33%
Western Blot
22%
Matrix Metalloproteinase
22%
Reperfusion Injury
22%
Nitric Oxide Synthase Inhibitor
22%
Messenger RNA
22%
Murine
11%
Neuroprotective Agent
11%
Tissue Injury
11%
Arginine Methyl Ester
11%
Neuroscience
MMP9
100%
Endothelial Nitric Oxide Synthase
100%
Agmatine
100%
Nitric Oxide
55%
MMP2
33%
Nitric Oxide Synthase
22%
Reperfusion Injury
22%
Matrix Metalloproteinase
22%
Messenger RNA
22%
Western Blotting
22%
Cell Death
11%
Neuroprotective Agent
11%
Basement Membrane
11%
Arginine Methyl Ester
11%
Biochemistry, Genetics and Molecular Biology